CL2014002891A1 - Dialisato a base de polímero; uso; kit para formular una solucion de dialisis; solucion de dialisis peritoneal; y metodo ex vivo para remover toxinas, moleculas, iones o productos de desecho de un fluido corporal. - Google Patents

Dialisato a base de polímero; uso; kit para formular una solucion de dialisis; solucion de dialisis peritoneal; y metodo ex vivo para remover toxinas, moleculas, iones o productos de desecho de un fluido corporal.

Info

Publication number
CL2014002891A1
CL2014002891A1 CL2014002891A CL2014002891A CL2014002891A1 CL 2014002891 A1 CL2014002891 A1 CL 2014002891A1 CL 2014002891 A CL2014002891 A CL 2014002891A CL 2014002891 A CL2014002891 A CL 2014002891A CL 2014002891 A1 CL2014002891 A1 CL 2014002891A1
Authority
CL
Chile
Prior art keywords
dialysis solution
formulating
kit
ions
molecules
Prior art date
Application number
CL2014002891A
Other languages
English (en)
Inventor
Jayachandran Kizhakkedathu
Caigan Du
Rosa Gerald Da
Asher Mendelson
Original Assignee
Univ British Columbia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ British Columbia filed Critical Univ British Columbia
Publication of CL2014002891A1 publication Critical patent/CL2014002891A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
    • A61M1/1654—Dialysates therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/28—Peritoneal dialysis ; Other peritoneal treatment, e.g. oxygenation
    • A61M1/287—Dialysates therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
    • C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
    • C08G65/04—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring from cyclic ethers only
    • C08G65/22—Cyclic ethers having at least one atom other than carbon and hydrogen outside the ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/0014—Special media to be introduced, removed or treated removed from the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/04—Liquids
    • A61M2202/0496—Urine
    • A61M2202/0498—Urea
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G2340/00—Filter material

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Emergency Medicine (AREA)
  • Diabetes (AREA)
  • Biomedical Technology (AREA)
  • Anesthesiology (AREA)
  • Vascular Medicine (AREA)
  • Obesity (AREA)
  • Polymers & Plastics (AREA)
  • Inorganic Chemistry (AREA)
  • Toxicology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • External Artificial Organs (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
  • Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
  • Polyethers (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Materials Applied To Surfaces To Minimize Adherence Of Mist Or Water (AREA)
CL2014002891A 2012-04-24 2014-10-24 Dialisato a base de polímero; uso; kit para formular una solucion de dialisis; solucion de dialisis peritoneal; y metodo ex vivo para remover toxinas, moleculas, iones o productos de desecho de un fluido corporal. CL2014002891A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201261637716P 2012-04-24 2012-04-24

Publications (1)

Publication Number Publication Date
CL2014002891A1 true CL2014002891A1 (es) 2015-05-04

Family

ID=49482059

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2014002891A CL2014002891A1 (es) 2012-04-24 2014-10-24 Dialisato a base de polímero; uso; kit para formular una solucion de dialisis; solucion de dialisis peritoneal; y metodo ex vivo para remover toxinas, moleculas, iones o productos de desecho de un fluido corporal.

Country Status (15)

Country Link
US (1) US9919004B2 (es)
EP (1) EP2841078A4 (es)
JP (1) JP6240665B2 (es)
KR (1) KR20150013161A (es)
CN (1) CN104640550A (es)
AU (1) AU2013252433B2 (es)
BR (1) BR112014026616A2 (es)
CA (1) CA2871277A1 (es)
CL (1) CL2014002891A1 (es)
CO (1) CO7190239A2 (es)
HK (1) HK1203388A1 (es)
MX (1) MX2014012942A (es)
MY (1) MY170307A (es)
PE (1) PE20150288A1 (es)
WO (1) WO2013159188A1 (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9346029B2 (en) 2005-06-06 2016-05-24 The University Of British Columbia Polymer-based serum albumin substitute
BR112012021991A2 (pt) 2010-03-01 2020-09-01 The University Of British Columbia policlicerol hiperramificado uso de um poliglicerol hipermanificado, método de adiministração de uma força biologicamente ativa a um tecido biológico, composição farmacêutica e método de síntese de um poliglicerol hiperrramificado.
CN105960165B (zh) * 2013-11-21 2021-03-23 李沙丹 基于聚合物的移植用保存溶液
WO2015179958A1 (en) 2014-05-29 2015-12-03 The University Of British Columbia Antithrombotic compounds, methods and uses thereof
EP3120842A1 (en) * 2015-07-20 2017-01-25 Opterion Health AG Peritoneal therapeutic fluid
US10874790B2 (en) 2016-08-10 2020-12-29 Medtronic, Inc. Peritoneal dialysis intracycle osmotic agent adjustment
GR1009311B (el) * 2017-01-26 2018-06-19 Βερμα Ντραγκς - Verma Drugs Abee Οξινο κιτρικο διαλυμα αιμοκαθαρσης με l-καρνιτινη
EP3381484A1 (en) * 2017-03-31 2018-10-03 Opterion Health AG Carbohydrate composition for dialysis
WO2019210414A1 (en) * 2018-05-02 2019-11-07 Arc Medical Devices Inc. Fucan-based compounds and complexes
US11806457B2 (en) * 2018-11-16 2023-11-07 Mozarc Medical Us Llc Peritoneal dialysis adequacy meaurements
US11806456B2 (en) 2018-12-10 2023-11-07 Mozarc Medical Us Llc Precision peritoneal dialysis therapy based on dialysis adequacy measurements
US11965763B2 (en) 2021-11-12 2024-04-23 Mozarc Medical Us Llc Determining fluid flow across rotary pump

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3461210A (en) * 1967-07-20 1969-08-12 Unimed Inc Reduction of intraocular pressure
JPS61247466A (ja) 1985-04-25 1986-11-04 テルモ株式会社 腹膜透析用透析液
US20030202958A1 (en) * 1999-10-15 2003-10-30 Strickland Alan D. Dialysis solution including polyglycol osmotic agent
EP1223985B1 (en) * 1999-10-15 2005-11-30 Dow Global Technologies Inc. Dialysis solution including polyglycol osmotic agent
US6949335B2 (en) * 1999-11-30 2005-09-27 21St Century Medicine, Inc. Polyglycerol and lactose compositions for the protection of living systems from states of reduced metabolism
US9346029B2 (en) * 2005-06-06 2016-05-24 The University Of British Columbia Polymer-based serum albumin substitute
DE102006036326A1 (de) * 2006-08-03 2008-02-07 Charité - Universitätsmedizin Berlin Dendritische Polyglycerolsulfate und -sulfonate und deren Verwendung bei entzündlichen Erkrankungen
WO2008074154A1 (en) 2006-12-18 2008-06-26 The University Of British Columbia Polymers comprising zwitterionic endgroups
WO2009055935A1 (en) 2007-11-02 2009-05-07 The University Of British Columbia Hyperbranched polyglycerol for improving heart function
BR112012021991A2 (pt) 2010-03-01 2020-09-01 The University Of British Columbia policlicerol hiperramificado uso de um poliglicerol hipermanificado, método de adiministração de uma força biologicamente ativa a um tecido biológico, composição farmacêutica e método de síntese de um poliglicerol hiperrramificado.
WO2012162789A1 (en) 2011-06-01 2012-12-06 University Of British Columbia Polymers for reversing heparin-based anticoagulation

Also Published As

Publication number Publication date
WO2013159188A1 (en) 2013-10-31
HK1203388A1 (en) 2015-10-30
BR112014026616A2 (pt) 2017-06-27
EP2841078A1 (en) 2015-03-04
KR20150013161A (ko) 2015-02-04
AU2013252433B2 (en) 2017-12-14
US20150141512A1 (en) 2015-05-21
JP6240665B2 (ja) 2017-11-29
CN104640550A (zh) 2015-05-20
MX2014012942A (es) 2015-02-10
JP2015515481A (ja) 2015-05-28
US9919004B2 (en) 2018-03-20
EP2841078A4 (en) 2015-11-04
PE20150288A1 (es) 2015-02-22
MY170307A (en) 2019-07-17
CA2871277A1 (en) 2013-10-31
AU2013252433A1 (en) 2014-11-20
CO7190239A2 (es) 2015-02-19

Similar Documents

Publication Publication Date Title
CL2014002891A1 (es) Dialisato a base de polímero; uso; kit para formular una solucion de dialisis; solucion de dialisis peritoneal; y metodo ex vivo para remover toxinas, moleculas, iones o productos de desecho de un fluido corporal.
BR112013026319A2 (pt) método e aparelho para o monitoramento de um tratamento de um paciente, preferivelmente para o monitoramento da hemodiálise, hemodiafiltração e/ou diálise peritoneal
HK1254856A1 (zh) 泵，特別是血液泵
FR2980712B1 (fr) Machine de dialyse comprenant des moyens d'ultrafiltration et de retrofiltration
MX2022008262A (es) Sistema y metodo para realizar modalidades de dialisis alternativa y secuencial de sangre y peritoneo.
CR20130466A (es) Método y sistema para tratar agua usada para procesos industriales
DK2868332T3 (da) Fluidpumpe, hvis diameter kan ændres, især til medicinsk anvendelse
EP2665499A4 (en) Flow estimation in a blood pump
BR112015002541A2 (pt) composto, composição farmacêutica, uso de um composto, e, método para tratamento de hcv em um paciente.
BR112013033758A2 (pt) recipiente, uso, dialisador ou unidade de preparação além de método para fabricação de um concentrado
DK2882421T3 (da) Liposom-sammensætning til brug i peritonealdialyse
MX2015004460A (es) Metodos para el tratamiento del sindrome de alport.
PH12015501787A1 (en) Systems and methods for ocular surgery
EA201001402A1 (ru) Фармацевтические растворы, способ получения и терапевтическое применение
MX2014001890A (es) Miembro de acoplamiento con la piel que comprende un agente antiirritante.
BRPI0918010A2 (pt) conector para recipiente descartável para ser usado em máquinas de diálise
EA201300814A1 (ru) Система обеспечения процесса лечения диализом, модуль гидравлики блока для системы обеспечения лечения диализом, одноразовый комплект трубок, одноразовая кассета, блок для осуществления лечения диализом
BRPI1006260A2 (pt) solução para hemodiálise peritoneal compreendendo um ou mais compostos de creatina
BR112015009110A2 (pt) sensor de fluido, e, método para uso na fabricação de um sensor de fluido.
EA201400994A1 (ru) Инфузионный адаптер для изменения давления внутри инфузионной магистрали в процессе лечения
BR112013022550A2 (pt) método para melhorar a retenção de membrana de osmose reversa, agente de tratamento para melhorar a retenção, e membrana de osmose reversa
SG11201401144UA (en) Peritoneal dialysis machine
BR112014028920A2 (pt) aparelho de filtragem para tratamento de um fluido, métodos para limpeza de um aparelho de filtragem e para fabricação de um aparelho de filtragem, e, módulo de filtragem.
BR112013015969A2 (pt) câmara para um sistema de tratamento de sangue, uso da câmara, sistema de tubagem de sangue e sistema de tratamento de sangue.
BR112015009111A2 (pt) sensor de fluido, e, método para uso na fabricação do sensor de fluido.